TITAN PHARMACEUTICALS INC — Director's Dealing 2007

Mar 22, 2007

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TITAN PHARMACEUTICALS INC (AMEX - TTP)
CIK: 0000910267
Period of Report: 2007-03-20

Reporting Person: FARRELL ROBERT EDWARD (Exec Vice President and CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2007-03-20	Common Stock	P	400	$2.29	Acquired	70480	Direct
2007-03-20	Common Stock	P	4000	$2.34	Acquired	74480	Direct
2007-03-20	Common Stock	P	2100	$2.31	Acquired	76580	Direct
2007-03-20	Common Stock	P	100	$2.30	Acquired	76680	Direct
2007-03-20	Common Stock	P	1000	$2.32	Acquired	77680	Direct
2007-03-20	Common Stock	P	18400	$2.40	Acquired	96080	Direct